Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Alzheimer's Disease

  Free Subscription


Articles published in JAMA

Retrieve available abstracts of 38 articles:
HTML format



Single Articles


    July 2021
  1. RUBIN R
    Recently Approved Alzheimer Drug Raises Questions That Might Never Be Answered.
    JAMA. 2021 Jul 21. pii: 2782427. doi: 10.1001/jama.2021.11558.
    PubMed    


  2. SCHULMAN KA, Greicius MD, Richman B
    Will CMS Find Aducanumab Reasonable and Necessary for Alzheimer Disease After FDA Approval?
    JAMA. 2021 Jul 19. pii: 2782333. doi: 10.1001/jama.2021.11768.
    PubMed    


    June 2021
  3. CHEN MH, Yang FC, Liang CS
    APOE Allele Testing and Alzheimer Disease.
    JAMA. 2021;325:2210-2211.
    PubMed    


  4. CHOUDHURY P, Ramanan VK, Boeve BF
    APOE Allele Testing and Alzheimer Disease-Reply.
    JAMA. 2021;325:2211.
    PubMed    


    April 2021
  5. RUBIN R
    Neurologist Faces His Alzheimer Diagnosis Determined to Lessen Stigma Surrounding the Disease.
    JAMA. 2021 Apr 28. pii: 2779452. doi: 10.1001/jama.2021.5333.
    PubMed    


    March 2021
  6. ALEXANDER GC, Emerson S, Kesselheim AS
    Evaluation of Aducanumab for Alzheimer Disease: Scientific Evidence and Regulatory Review Involving Efficacy, Safety, and Futility.
    JAMA. 2021 Mar 30. pii: 2778191. doi: 10.1001/jama.2021.3854.
    PubMed    


    January 2021
  7. CHOUDHURY P, Ramanan VK, Boeve BF
    APOE varepsilon4 Allele Testing and Risk of Alzheimer Disease.
    JAMA. 2021 Jan 14. pii: 2775399. doi: 10.1001/jama.2020.15085.
    PubMed    


    November 2020
  8. MADDOX M
    Alzheimer Aubade.
    JAMA. 2020;324:2108.
    PubMed    


    October 2020
  9. TSOU AY, Bulova P, Capone G, Chicoine B, et al
    Medical Care of Adults With Down Syndrome: A Clinical Guideline.
    JAMA. 2020;324:1543-1556.
    PubMed     Abstract available


    July 2020
  10. PALMQVIST S, Janelidze S, Quiroz YT, Zetterberg H, et al
    Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders.
    JAMA. 2020 Jul 28. pii: 2768841. doi: 10.1001/jama.2020.12134.
    PubMed     Abstract available


    June 2020
  11. KOMAROFF AL
    Can Infections Cause Alzheimer Disease?
    JAMA. 2020 Jun 8. pii: 2767210. doi: 10.1001/jama.2020.4085.
    PubMed    


    April 2020
  12. ABBASI J
    Alzheimer Blood Test Using Tau Biomarker Is in Development.
    JAMA. 2020;323:1336.
    PubMed    


    February 2020
  13. PATNODE CD, Perdue LA, Rossom RC, Rushkin MC, et al
    Screening for Cognitive Impairment in Older Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    JAMA. 2020;323:764-785.
    PubMed     Abstract available


  14. ABBASI J
    Ultrasound Brain Stimulation Piloted in Alzheimer Study.
    JAMA. 2020;323:499.
    PubMed    


  15. BORELLI CM, Grennan D, Muth CC
    Causes of Memory Loss in Elderly Persons.
    JAMA. 2020;323:486.
    PubMed    


    January 2020
  16. KUEHN BM
    In Alzheimer Research, Glucose Metabolism Moves to Center Stage.
    JAMA. 2020 Jan 8. pii: 2758712. doi: 10.1001/jama.2019.20939.
    PubMed    


    October 2019
  17. ARVANITAKIS Z, Shah RC, Bennett DA
    Diagnosis and Management of Dementia: Review.
    JAMA. 2019;322:1589-1599.
    PubMed     Abstract available


    July 2019
  18. HAMPTON T
    For Alzheimer Pathology, Light and Sound Stimulation May Hold Promise.
    JAMA. 2019;322:17-18.
    PubMed    


    June 2019
  19. WOLK D, Salloway S, Dickerson B
    Putting the New Alzheimer Disease Amyloid, Tau, Neurodegeneration (AT[N]) Diagnostic System to the Test.
    JAMA. 2019;321:2289-2291.
    PubMed    


    April 2019
  20. HAMPTON T
    Studies Further Support Transmissibility of Alzheimer Disease-Associated Proteins.
    JAMA. 2019;321:1243-1244.
    PubMed    


  21. RABINOVICI GD, Gatsonis C, Apgar C, Chaudhary K, et al
    Association of Amyloid Positron Emission Tomography With Subsequent Change in Clinical Management Among Medicare Beneficiaries With Mild Cognitive Impairment or Dementia.
    JAMA. 2019;321:1286-1294.
    PubMed     Abstract available


    December 2018
  22. GLAZNER G, Kaplan DB
    The Alzheimer's Poetry Project.
    JAMA. 2018;320:2294-2295.
    PubMed    


    November 2018
  23. KUEHN B
    Alzheimer Burden.
    JAMA. 2018;320:1851.
    PubMed    


    September 2018
  24. OSSENKOPPELE R, Rabinovici GD, Smith R, Cho H, et al
    Discriminative Accuracy of [18F]flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative Disorders.
    JAMA. 2018;320:1151-1162.
    PubMed     Abstract available


  25. ABBASI J
    Promising Results in 18-Month Analysis of Alzheimer Drug Candidate.
    JAMA. 2018;320:965.
    PubMed    


    June 2018
  26. SLOMSKI A
    Abeta-Clearing Drug Fails to Slow Alzheimer Disease.
    JAMA. 2018;319:2470.
    PubMed    


    March 2018
  27. ABBASI J
    Plasma Biomarkers Predict Brain Amyloid-beta Burden.
    JAMA. 2018;319:972.
    PubMed    


    January 2018
  28. ATRI A, Frolich L, Ballard C, Tariot PN, et al
    Effect of Idalopirdine as Adjunct to Cholinesterase Inhibitors on Change in Cognition in Patients With Alzheimer Disease: Three Randomized Clinical Trials.
    JAMA. 2018;319:130-142.
    PubMed     Abstract available


  29. BENNETT DA
    Lack of Benefit With Idalopirdine for Alzheimer Disease: Another Therapeutic Failure in a Complex Disease Process.
    JAMA. 2018;319:123-125.
    PubMed    


    October 2017
  30. ABBASI J
    A Retinal Scan for Alzheimer Disease.
    JAMA. 2017;318:1314.
    PubMed    


  31. DONOHUE MC, Aisen PS
    Elevated Brain Amyloid in Cognitively Normal Individuals-Reply.
    JAMA. 2017;318:1393-1394.
    PubMed    


  32. GAO R, Chen C, Zhu T
    Elevated Brain Amyloid in Cognitively Normal Individuals.
    JAMA. 2017;318:1392-1393.
    PubMed    


    June 2017
  33. VISSER PJ, Tijms B
    Brain Amyloid Pathology and Cognitive Function: Alzheimer Disease Without Dementia?
    JAMA. 2017;317:2285-2287.
    PubMed    


  34. DONOHUE MC, Sperling RA, Petersen R, Sun CK, et al
    Association Between Elevated Brain Amyloid and Subsequent Cognitive Decline Among Cognitively Normal Persons.
    JAMA. 2017;317:2305-2316.
    PubMed     Abstract available


    May 2017
  35. SABAYAN B, Sorond F
    Reducing Risk of Dementia in Older Age.
    JAMA. 2017;317:2028.
    PubMed    


    April 2017
  36. GOTTESMAN RF, Schneider AL, Zhou Y, Coresh J, et al
    Association Between Midlife Vascular Risk Factors and Estimated Brain Amyloid Deposition.
    JAMA. 2017;317:1443-1450.
    PubMed     Abstract available


    February 2017
  37. LYON J
    Alzheimer Outlook Far From Bleak.
    JAMA. 2017 Feb 15. doi: 10.1001/jama.2017.0276.
    PubMed    


    December 2016
  38. LYON J
    Study Suggests Alzheimer and Parkinson Disease Are Not Transmitted Through Blood Transfusion.
    JAMA. 2016 Dec 21. doi: 10.1001/jama.2016.16260.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: